News
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...
Scott C. Maloney, MBA, has served as the founder and senior partner at Crain & Company since 2009, where he is responsible ...
CAMBRIDGE, Mass. - Sarepta Therapeutics, Inc. (NASDAQ: SRPT) shares jumped 3.7% after the precision genetic medicine company reported second-quarter earnings that significantly exceeded analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback